| ELISA kit stock availability: |
Available In Stock |
| ELISA's description: |
Human Glucagon like peptide 2 receptor (GLP2R) Control/blocking peptide #2 |
| Category: |
Antibody Blocking Peptide |
| S type: |
Synthetic peptide (inquire immunogen) |
| Antibody's host is: |
see techfile |
| Purification: |
Affinity purified |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), blocking peptide, humans , ssp |
| Description: |
, 2 or 3 and , However, In this sense, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The receptors are ligand binding factors of type 1, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, and unbranched synthetic peptide chains, chemokinesor cytokines e, consisting of 2 amino acids joined by a single peptide bond, continuous, e, followed by tripeptides, or in continue produced for custom peptide synthesis projects, sometimes in pharmacology, such as enzymes, tetra peptides, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, till polypeptides that are long, transporters and ion-channels, Peptides short amino acid chains or epitopes or blocking antagonists, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell |
| Gene target: |
Glucagon like peptide 2 receptor (GLP2R) / #2 |
| Short name: |
Glucagon like peptide 2 receptor (GLP2R) Control/blocking peptide #2 |
| Technique: |
For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear, This is called a negative control by blocking the WB antibody, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1, controls, peptides, blocking peptide |
| Species: |
Humans, Human |
| Alternative name: |
sapiens Glucagon like short protein sequence 2 receptor (GLP2R) reference/inhibiting short protein sequence #2, H |
| Alternative technique: |
controls |
| Identity: |
4325 |
| Gene: |
GLP2R |
More about : GLP2R |
| Long gene name: |
glucagon like peptide 2 receptor |
| Synonyms gene name: |
glucagon-like peptide 2 receptor |
| Locus: |
17p13, 1 |
| Discovery year: |
1999-02-23 |
| GenBank acession: |
AF105367 |
| Entrez gene record: |
9340 |
| Pubmed identfication: |
9990065 |
| Classification: |
Glucagon receptor family |
| Havana BLAST/BLAT: |
OTTHUMG00000130269 |